An Australian based Study on the Patterns of Short Acting Beta-2 Agonist (SABA) use and Its Potential Effects on Asthma Control (SABINA Australia)First published 03/07/2023 Last updated 21/02/2024 EU PAS number: EUPAS105682StudyOngoing